Posts classified under: UCLA Cannabinoid

Igor Spigelman, Ph.D.

Publications

A selected list of publications:

Shen Yi, Lindemeyer A Kerstin, Spigelman Igor, Sieghart Werner, Olsen Richard W, Liang Jing   Plasticity of GABAA receptors after ethanol pre-exposure in cultured hippocampal neurons Molecular pharmacology, 2011; 79(3): 432-42.
Ruangsri Supanigar, Lin Audrey, Mulpuri Yatendra, Lee Kyung, Spigelman Igor, Nishimura Ichiro   RELATIONSHIP OF AXONAL VOLTAGE-GATED SODIUM CHANNEL 1.8 (NaV1.8) mRNA ACCUMULATION TO SCIATIC NERVE INJURY-INDUCED PAINFUL NEUROPATHY IN RATS The Journal of biological chemistry, 2011; .
Suryanarayanan Asha, Liang Jing, Meyer Edward M, Lindemeyer A Kerstin, Chandra Dev, Homanics Gregg E, Sieghart Werner, Olsen Richard W, Spigelman Igor   Subunit Compensation and Plasticity of Synaptic GABA(A) Receptors Induced by Ethanol in ?4 Subunit Knockout Mice Frontiers in neuroscience, 2011; 5(3): 110.
Díaz-Cintra Sofia, Xue Baogang, Spigelman Igor, Van K, Wong Alan M, Obenaus Andre, Ribak Charles E   Dentate granule cells form hilar basal dendrites in a rat model of hypoxia-ischemia Brain research, 2009; 1285: 182-7.
Thakor Devang Kashyap, Lin Audrey, Matsuka Yoshizo, Meyer Edward M, Ruangsri Supanigar, Nishimura Ichiro, Spigelman Igor   Increased peripheral nerve excitability and local NaV1.8 mRNA up-regulation in painful neuropathy Molecular pain, 2009; 5(1): 14.
Ribak Charles E, Shapiro Lee A, Perez Zachary D, Spigelman Igor   Microglia-associated granule cell death in the normal adult dentate gyrus Brain structure & function, 2009; .
Matsuka Yoshizo, Ono Takeshi, Iwase Hirotate, Mitrirattanakul Somsak, Omoto Kevin S, Cho Ting, Lam Yan Yan N, Snyder Bradley, Spigelman Igor   Altered ATP release and metabolism in dorsal root ganglia of neuropathic rats Molecular pain, 2008; 4(1): 66.
Jain Naveen K, Ishikawa Tomo-o, Spigelman Igor, Herschman Harvey R   COX-2 expression and function in the hyperalgesic response to paw inflammation in mice Prostaglandins, leukotrienes, and essential fatty acids, 2008; 79(6): 183-90.
Liang Jing, Suryanarayanan Asha, Chandra Dev, Homanics Gregg E, Olsen Richard W, Spigelman Igor   Functional consequences of GABAA receptor alpha 4 subunit deletion on synaptic and extrasynaptic currents in mouse dentate granule cells Alcoholism, clinical and experimental research, 2008; 32(1): 19-26.
Chandra Dev, Werner David F, Liang Jing, Suryanarayanan Asha, Harrison Neil L, Spigelman Igor, Olsen Richard W, Homanics Gregg E   Normal acute behavioral responses to moderate/high dose ethanol in GABAA receptor alpha 4 subunit knockout mice Alcoholism, clinical and experimental research, 2008; 32(1): 10-8.
Mitrirattanakul Somsak, López-Valdés Héctor E, Liang Jing, Matsuka Yoshizo, Mackie Ken, Faull Kym F, Spigelman Igor   Bidirectional alterations of hippocampal cannabinoid 1 receptors and their endogenous ligands in a rat model of alcohol withdrawal and dependence Alcoholism, clinical and experimental research, 2007; 31(5): 855-67.
Liang Jing, Suryanarayanan Asha, Abriam Alana, Snyder Bradley, Olsen Richard W, Spigelman Igor   Mechanisms of reversible GABAA receptor plasticity after ethanol intoxication The Journal of neuroscience : the official journal of the Society for Neuroscience, 2007; 27(45): 12367-77.
Thakor Devang, Spigelman Igor, Tabata Yasuhiko, Nishimura Ichiro   Subcutaneous peripheral injection of cationized gelatin/DNA polyplexes as a platform for non-viral gene transfer to sensory neurons Molecular therapy : the journal of the American Society of Gene Therapy, 2007; 15(12): 2124-31.
Liang, J., Zhang, N., Cagetti, E. Houser, C.R., Olsen, R.W. and Spigelman, I.   Chronic intermittent ethanol treatment-induced switch of ethanol actions from extrasynaptic to synaptic hippocampal GABAA receptors, Journal of Neuroscience, 2006; 26: 1749-1758.
Liang Jing, Zhang Nianhui, Cagetti Elisabetta, Houser Carolyn R, Olsen Richard W, Spigelman Igor   Chronic intermittent ethanol-induced switch of ethanol actions from extrasynaptic to synaptic hippocampal GABAA receptors The Journal of neuroscience : the official journal of the Society for Neuroscience, 2006; 26(6): 1749-58.
Chandra, D., Jia, F., Liang, J., Peng, Z., Suryanarayanan, A., Werner, D.F., Spigelman, I., Houser, C.R., Olsen, R.W., Harrison, N.L. and Homanics, G.E.   GABA(A) receptor alpha4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol, Proceedings of the National Academy of Sciences USA, 2006; 103: 15230-15235.
Spigelman, I.   Physiologic mechanisms of inhibition and status epilepticus, In: Status Epilepticus, Mechanisms and Management, C.G. Wasterlain and D.M. Treiman editors, MIT Press, Cambridge,, 2006; Chapter 21: 281-293.
Mitrirattanakul Somsak, Ramakul Navapoln, Guerrero Andre V, Matsuka Yoshizo, Ono Takeshi, Iwase Hirotate, Mackie Ken, Faull Kym F, Spigelman Igor   Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain Pain, 2006; 126(1-3): 102-14.
Olsen, R.W., Liang, J., Cagetti, E., and Spigelman, I.   Plasticity of GABAA receptors in brains of rats treated with chronic intermittent ethanol , Neurochemical Research, 2005; 30: 1579-1588.
Matsuka Y. and Spigelman, I.   Hyperosmolar solutions selectively block action potentials in rat myelinated sensory fibers: implications for diabetic neuropathy, Journal of Neurophysiology, 2004; 91: 48-56.
Matsuka, Y Neubert, JK Maidment, NT Spigelman, I   Concurrent release of ATP and substance P within guinea pig trigeminal ganglia in vivo Brain research. , 2001; 915(2): 248-55.
Spigelman, I., Gold, M.S., Light A.R.   Electrophysiological Methods in Pain Research, Methods in Pain Research, 2001; Chapter 8: 147-168.
Spigelman, I., Neubert, J.K., Matsuka, Y., Maidment, N.T.   Extracellular Sampling, Methods in Pain Research, 2001; Chapter 7: 133-146.
Neubert, JK Maidment, NT Matsuka, Y Adelson, DW Kruger, L Spigelman, I   Inflammation-induced changes in primary afferent-evoked release of substance P within trigeminal ganglia in vivo Brain research. , 2000; 871(2): 181-91.
Spigelman, I Yan, XX Obenaus, A Lee, EY Wasterlain, CG Ribak, CE   Dentate granule cells form novel basal dendrites in a rat model of temporal lobe epilepsy Neuroscience. , 1998; 86(1): 109-20.
Spigelman, I Obenaus, A Mazarati, A Wasterlain, CG   Intravenously administered cell-permeant calcium buffer decreases evoked synaptic potentials in rat dentate gyrus in vivo Brain research. , 1998; 810(1-2): 269-73.

Ziva Cooper, Ph.D.

Publications

A selected list of publications:

Lake Stephanie, Walsh Zach, Kerr Thomas, Cooper Ziva D, Buxton Jane, Wood Evan, Ware Mark A, Milloy M J   Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis PLoS medicine, 2019; 16(11): e1002967.
Bedi Gillinder, Hao Xuejun, Van Dam Nicholas T, Cooper Ziva D, Rubin Eric, Vadhan Nehal P, Marino Leslie, Haney Margaret   Social motivational processing and interpersonal function in aging cocaine smokers Addiction biology, 2019; 24(5): 1044-1055.
Adinoff Bryon, Cooper Ziva D   Cannabis legalization: progress in harm reduction approaches for substance use and misuse The American journal of drug and alcohol abuse, 2019; 45(6): 707-712.
Chao Thomas, Haney Margaret, Cooper Ziva D, Vadhan Nehal P, Van Dam Nicholas T, Van Snellenberg Jared, Bedi Gillinder   Cognitive function in aging cocaine smokers Journal of psychopharmacology (Oxford, England), 2019; 33(7): 801-810.
Haney Margaret, Cooper Ziva D, Bedi Gillinder, Herrmann Evan, Comer Sandra D, Reed Stephanie Collins, Foltin Richard W, Levin Frances R   Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers Addiction biology, 2019; 24(4): 707-716.
Cooper Ziva D, Adinoff Bryon   Necessity of addressing motivations for cannabis use to guide research The American journal of drug and alcohol abuse, 2019; 45(6): 547-550.
Herrmann Evan S, Cooper Ziva D, Bedi Gillinder, Ramesh Divya, Reed Stephanie Collins, Comer Sandra D, Foltin Richard W, Haney Margaret   Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse Addiction biology, 2019; 24(4): 765-776.
Cooper Ziva D, Bedi Gillinder, Ramesh Divya, Balter Rebecca, Comer Sandra D, Haney Margaret   Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018; 43(10): 2046-2055.
Piomelli Daniele, Weiss Susan, Boyd Graham, Pacula Rosalie Liccardo, Cooper Ziva   Cannabis and the Opioid Crisis Cannabis and cannabinoid research, 2018; 3(1): 108-116.
Cooper Ziva D, Poklis Justin L, Liu Fei   Methodology for controlled administration of smoked synthetic cannabinoids JWH-018 and JWH-073 Neuropharmacology, 2018; 134(Pt A): 92-100.
Cooper Ziva D, Craft Rebecca M   Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018; 43(1): 34-51.
Piomelli Daniele, Cooper Ziva, Abrams Donald, Grant Igor, Patel Sachin   A Guide to the National Academy of Science Report on Cannabis: An Exclusive Discussion with Panel Members Cannabis and cannabinoid research, 2017; 2(1): 155-159.
Cooper Ziva D, Haney Margaret   Sex-dependent effects of cannabis-induced analgesia Drug and alcohol dependence, 2016; 167(1): 112-20.
Herrmann Evan S, Cooper Ziva D, Bedi Gillinder, Ramesh Divya, Reed Stephanie C, Comer Sandra D, Foltin Richard W, Haney Margaret   Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users Psychopharmacology, 2016; 233(13): 2469-78.
Haney Margaret, Malcolm Robert J, Babalonis Shanna, Nuzzo Paul A, Cooper Ziva D, Bedi Gillinder, Gray Kevin M, McRae-Clark Aimee, Lofwall Michelle R, Sparenborg Steven, Walsh Sharon L   Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016; 41(8): 1974-82.
Cooper Ziva D, Johnson Kirk W, Pavlicova Martina, Glass Andrew, Vosburg Suzanne K, Sullivan Maria A, Manubay Jeanne M, Martinez Diana M, Jones Jermaine D, Saccone Phillip A, Comer Sandra D   The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers Addiction biology, 2016; 21(4): 895-903.
Cooper Ziva D   Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal Current psychiatry reports, 2016; 18(5): 52.
Haney Margaret, Ramesh Divya, Glass Andrew, Pavlicova Martina, Bedi Gillinder, Cooper Ziva D   Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015; 40(11): 2489-98.
Balter Rebecca E, Cooper Ziva D, Haney Margaret   Novel Pharmacologic Approaches to Treating Cannabis Use Disorder Current addiction reports, 2014; 1(2): 137-143.

Catherine Cahill, M.Sc., Ph.D.

Biography

Catherine M. Cahill, Ph.D. trained as an opioid neuropharmaoclogist at Dalhousie University, Canada receiving her PhD in 1996. She was recruited to the Department of Anesthesiology and Perioperative Care at University of California Irvine in 2012 from Queen’s University in Canada where she held a Canada Research Chair in Chronic Pain for 10 years. She moved to UCLA in 2017 and is now a Professor in the Department of Psychiatry & Biobehavioral Sciences and a member of the Hatos Center for Neuropharmacology at the University of California Los Angeles.

She has more than 25 years experience in research that focuses on understanding mechanisms of chronic pain and opioid analgesia, tolerance, dependence and addiction. Her research spans both basic science and human research, which focuses on how chronic pain states modulate reward circuitry and changes dopaminergic transmission responsible for motivated behavior. A large emphasis of her research focuses on understanding the processes that influence the positive and negative reinforcement and changes in mesolimbic circuitry in order to identify novel treatment strategies for opioid dependence and chronic pain.

Dr. Cahill’s research is supported by the National Institutes of Drug abuse, the National Center for Advancing Translational Sciences, the National Institute of Aging, the National Institute of Dental and Craniofacial Research, the Department of Defense and the Shirley and Stefan Hatos Foundation.